ND-L11B free base
ND-L11B free base is an NSD2 degrader with a Kd value of 8.77 μM, degrading the NSD2-long and RE-IIBP isoforms in multiple myeloma cells with DC50 values of 1.48 μM and 0.8 μM, respectively. ND-L11B free base reduces H3K36me2 levels and inhibits the proliferation of multiple myeloma cells. ND-L11B free base serves as a starting point for the further development of NSD2-targeted compounds and is also a chemical knockdown tool for elucidating the multiple functions of NSD2 isoforms. ND-L11B free base can be used for research on multiple myeloma.
For research use only. We do not sell to patients.
- Formula: C37H51F3N10O2
- Molecular Weight:724.86
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Histone Methyltransferase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
NSD2 8.77 μM (Kd) |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| KMS-11 | DC50 |
1.48 μM
|
Degradation of NSD2-long isoform in human KMS11 multiple myeloma cells assessed via immunoblotting.
Degradation of NSD2-long isoform in human KMS11 multiple myeloma cells assessed via immunoblotting.
|
39705735 |
| KMS-11 | DC50 |
0.80 μM
|
Degradation of RE-IIBP isoform in human KMS11 multiple myeloma cells assessed via immunoblotting.
Degradation of RE-IIBP isoform in human KMS11 multiple myeloma cells assessed via immunoblotting.
|
39705735 |
| KMS-11 | IC50 |
0.90 μM
|
Inhibition of cell proliferation in human KMS11 multiple myeloma cells assessed as reduction in cell viability after 12 days by cell viability assay.
Inhibition of cell proliferation in human KMS11 multiple myeloma cells assessed as reduction in cell viability after 12 days by cell viability assay.
|
39705735 |
| HEK-293T | IC50 |
> 100 μM
|
Inhibition of cell viability in human 293T embryonic kidney cells assessed after 8 days by cell viability assay.
Inhibition of cell viability in human 293T embryonic kidney cells assessed after 8 days by cell viability assay.
|
39705735 |
In Vitro
ND-L11B free base (0.63-2.50 μM for KMS11 cells; 2.0-8.0 μM for 22RV1 cells) downregulates H3K36 methylation levels in KMS11 multiple myeloma cells and 22RV1 prostate cancer cells[1].
ND-L11B free base (12-day exposure of KMS11 cells; 8-day exposure of 293T cells) potently inhibits the proliferation of KMS11 multiple myeloma cells with an IC50 of 0.90 μM, while showing very low cytotoxicity against non-malignant human embryonic kidney 293T cells (IC50 > 100 μM)[1].
ND-L11B free base (1.25-2.50 μM; 2 days) downregulates the expression of NSD2-regulated cancer-related genes in KMS11 multiple myeloma cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:KMS11 multiple myeloma cells
-
Concentration:0.09, 0.13, 0.20, 0.29, 0.44, 0.66, 0.99, 1.48, 2.22, 3.33, 5.0 μM; 5 μM (time-dependent assay)
-
Incubation Time:6, 12, 24, 36, 48 h (5 μM concentration)
-
Result:Induced simultaneous concentration-dependent degradation of NSD2-long and RE-IIBP isoforms, with DC50 values of 1.48 μM (NSD2-long) and 0.80 μM (RE-IIBP), and a maximum degradation (D_max) of approximately 80%.
Induced time-dependent degradation of NSD2 protein over 6 to 48 hours.
-
Cell Line:KMS11 multiple myeloma cells
-
Concentration:1.25, 2.50 μM
-
Incubation Time:2 days
-
Result:Downregulated the expression of NSD2-regulated oncogenes and cancer-related genes including JAM2, MET, PAK1, RRAS2, BACE2, CA2, IGF2BP2, and CR2.
Chemical Information
-
Molecular Weight 724.86
-
Formula C37H51F3N10O2
-
SMILES
O=C(NCCCCCCCCCCCN)COC1=CC(C2=NC=C(N3C[C@](CC(F)F)(N)CCC3)C(CN4C=NC5=C(N)N=CN=C45)=C2)=CC=C1F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)